Thus, we conclude that miR-338 inhibits gastric cancer cell migration, invasion and proliferation, as well as promoting apoptosis, by decreasing the expression of NRP1, which increases ERK, Akt and P38MAPK signaling. The gene discussed is NRP1; the disease is gastric cancer.